| Full Name | Dentist 4 U |
|---|---|
| Speciality | Dentist |
| Location | 186 Broadway, Port Ewen, New York |
| Authorized Official Name and Position | Irina Lopatnyuk (PRESIDENT) |
| Authorized Official Contact | 8453319150 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Dentist 4 U 58 Jefferson St Highland Mills NY 10930-2726 Ph: (845) 928-4723 | Dentist 4 U 186 Broadway Port Ewen NY 12466 Ph: (845) 331-9150 |
| NPI Number | 1154512655 |
|---|---|
| Provider Enumeration Date | 08/08/2007 |
| Last Update Date | 08/08/2007 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154512655 | NPI | - | NPPES |
| 02382396 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 044997-1 (New York) | Primary |
News Archive
Researchers at Boston Children's Hospital have identified a genetic cause of severe obesity that, though rare, raises new questions about weight gain and energy use in the general obese population. The research, published in the journal Science on July 19, involved genetic surveys of several groups of obese humans and experiments in mice.
Researchers from the MassGeneral Institute for Neurodegenerative Disorders (MGH-MIND) have discovered how the death of brain cells caused by a stroke or head injury may cause generation of amyloid-beta protein ? the key component of senile plaques seen in the brains of patients with Alzheimer's disease.
Representatives from over 20 different healthcare organisations will be convening at the University of Leicester on 11 June to discuss how old patterns of patient safety and historical complaints against doctors are still being replicated in the modern welfare system - and what lessons can be learned by looking to our medical past.
Neutra Corp., a provider of all-natural wellness solutions, welcoms a new law passed in Nevada last week allowing medical marijuana patients to obtain their medicine from dispensaries at last.
Genentech, a member of the Roche Group, announced today that people with HER2-positive metastatic breast cancer (mBC) lived significantly longer (overall survival) when treated with the combination of Perjeta (pertuzumab), Herceptin (trastuzumab) and docetaxel chemotherapy, compared to Herceptin and docetaxel chemotherapy alone in the Phase III CLEOPATRA study.
› Verified 3 days ago
Hudson Valley Dentist 4u Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 186 Broadway, Port Ewen, NY 12466 Phone: 845-331-9150 Fax: 718-851-0240 |